Vaxart, Inc. (VXRT)
NASDAQ: VXRT · IEX Real-Time Price · USD
0.680
+0.005 (0.76%)
Jul 22, 2024, 9:55 AM EDT - Market open
Vaxart Employees
Vaxart had 109 employees as of December 31, 2023. The number of employees decreased by 55 or -33.54% compared to the previous year.
Employees
109
Change (1Y)
-55
Growth (1Y)
-33.54%
Revenue / Employee
$81,514
Profits / Employee
-$749,927
Market Cap
154.67M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
High Tide | 1,550 |
Lifecore Biomedical | 459 |
Rani Therapeutics Holdings | 140 |
OptiNose | 132 |
Kodiak Sciences | 111 |
Capricor Therapeutics | 102 |
Assertio Holdings | 53 |
Achieve Life Sciences | 22 |
VXRT News
- 4 weeks ago - Vaxart Provides Business Update - GlobeNewsWire
- 5 weeks ago - Vaxart Announces $40 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate - GlobeNewsWire
- 2 months ago - Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers - GlobeNewsWire
- 4 months ago - Vaxart to Present at World Vaccine Congress Washington 2024 on April 3 - GlobeNewsWire
- 4 months ago - Vaxart Provides Business Update and Reports Full Year 2023 Financial Results - GlobeNewsWire